SEC Company Response from Bionano Genomics, Inc. (BNGO) (CIK 0001411690) (BNGO) — Apr 15, 2019
Bionano Genomics, Inc. (BNGO) (CIK 0001411690)
Date: April 15, 2019 · CIK: 0001411690 · Accession: 0001193125-19-106779
AI Filing Summary & Sentiment
File numbers found in text: 333-230588
Show Raw Text
CORRESP 1 filename1.htm CORRESP Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Heather Percival Re: Bionano Genomics, Inc. Registration Statement on Form S-1 File No. 333-230588 Acceleration Request Requested Date: Wednesday, April 17, 2019 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-230588) (the “Registration Statement”) to become effective on April 17, 2019, at 4:00 P.M., Eastern Time, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with James Pennington of Cooley LLP, counsel to the Registrant, at (858) 550-6029. Very truly yours, Bionano Genomics, Inc. By: /s/ R. Erik Holmlin, Ph.D. R. Erik Holmlin, Ph.D. President and Chief Executive Officer cc: Mike Ward, Bionano Genomics, Inc. James Pennington, Cooley LLP